ClinVar Miner

Submissions for variant NM_001018005.2(TPM1):c.632C>G (p.Ala211Gly)

dbSNP: rs397516487
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000036630 SCV000060285 uncertain significance not specified 2015-07-22 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Pathogenic. The p.Ala211Gly variant in TPM1 has been previously identified by our laboratory in 1 Caucasian adult with DCM (Lakdawala 2012). Limited family studies are consistent with a disease causing role but insufficient to establish this with certainty (LMM unpu blished data). This variant was absent from large population studies (dbSNP rs39 7516487). Alanine (Ala) at position 211 is highly conserved in evolution and the change to glycine (Gly) was predicted to be pathogenic using a computational to ol clinically validated by our laboratory. This tool's pathogenic prediction is estimated to be correct 94% of the time (Jordan 2011). However, this information is not predictive enough to determine pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Ala211 Gly variant is uncertain.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.